General MedicationsORALStandard

GLIPIZIDE AND METFORMIN HYDROCHLORIDE

GLIPIZIDE; METFORMIN HYDROCHLORIDE

Standard Dose

2.5MG;500MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview GLIPIZIDE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 078905 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GLIPIZIDE; METFORMIN HYDROCHLORIDE Form and strength TABLET;ORAL - 2.5MG;500MG Sponsor ZYDUS PHARMS USA INC Submission history Latest submission status date: 2017-04-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview GLIPIZIDE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 078905 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GLIPIZIDE; METFORMIN HYDROCHLORIDE Form and strength TABLET;ORAL - 2.5MG;500MG Sponsor ZYDUS PHARMS USA INC Submission history Latest submission status date: 2017-04-05 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.